Richard Scott Blackley Sells 18,750 Shares of Oscar Health (NYSE:OSCR) Stock

Oscar Health, Inc. (NYSE:OSCR) CFO Richard Scott Blackley sold 18,750 shares of the company’s stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $31.74, for a total transaction of $595,125.00. Following the completion of the transaction, the chief financial officer directly owned 56,250 shares of the company’s stock, valued at $1,785,375. This represents a 25.00% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link.

Richard Scott Blackley also recently made the following trade(s):

• On Tuesday, June 2nd, Richard Scott Blackley sold 31,683 shares of Oscar Health stock. The stock was sold at an average price of $21.94, for a total value of $695,125.02.

Oscar Health Stock Up 0.8%

Shares of OSCR opened at $31.81 on Friday. The business’s 50 day moving average is $30.03 and its 200 day moving average is $21.44. The company has a current ratio of 1.09, a quick ratio of 1.09 and a debt-to-equity ratio of 0.21. Oscar Health, Inc. has a 12-month low of $10.69 and a 12-month high of $33.48. The company has a market capitalization of $9.82 billion, a PE ratio of 22.72, a price-to-earnings-growth ratio of 0.65 and a beta of 2.36.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings results on Thursday, August 6th. The company reported $1.10 earnings per share for the quarter, topping the consensus estimate of $0.40 by $0.70. Oscar Health had a return on equity of 38.45% and a net margin of 3.60%.The business had revenue of $4.88 billion during the quarter, compared to the consensus estimate of $4.73 billion. During the same period in the prior year, the company posted ($0.89) EPS. The firm’s revenue for the quarter was up 70.4% compared to the same quarter last year. Research analysts expect that Oscar Health, Inc. will post 1.54 earnings per share for the current fiscal year.

Institutional Trading of Oscar Health

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Thrive Capital Management LLC lifted its position in Oscar Health by 33.4% in the fourth quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company’s stock worth $85,258,000 after buying an additional 1,588,395 shares during the last quarter. Baird Financial Group Inc. purchased a new position in Oscar Health during the first quarter worth $159,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in Oscar Health by 4.3% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 215,650 shares of the company’s stock valued at $2,827,000 after acquiring an additional 8,879 shares during the last quarter. Jones Financial Companies Lllp increased its position in Oscar Health by 7,473.3% during the first quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock valued at $30,000 after acquiring an additional 2,242 shares during the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in shares of Oscar Health by 39.0% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 470,590 shares of the company’s stock valued at $6,169,000 after acquiring an additional 132,149 shares during the period. Hedge funds and other institutional investors own 75.70% of the company’s stock.

Analyst Ratings Changes

Several analysts have commented on OSCR shares. Wall Street Zen upgraded shares of Oscar Health from a “buy” rating to a “strong-buy” rating in a research note on Sunday, June 14th. Weiss Ratings raised Oscar Health from a “sell (d+)” rating to a “hold (c+)” rating in a research note on Tuesday, August 11th. Wells Fargo & Company raised their price target on Oscar Health from $20.00 to $27.00 and gave the company an “equal weight” rating in a report on Thursday, August 13th. Piper Sandler reaffirmed an “overweight” rating and issued a $36.00 price objective on shares of Oscar Health in a research note on Tuesday, July 28th. Finally, Barclays upped their price objective on Oscar Health from $35.00 to $39.00 and gave the stock an “overweight” rating in a report on Thursday, August 6th. One research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and eight have given a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $26.22.

Oscar Health Company Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.